S. 2658Reported
Medication Affordability and Patent Integrity Act
Establishes medication affordability and patent integrity rules to curb patent abuse that can delay lower-cost drugs
Plain-English overview
What this bill does
Establishes medication affordability and patent integrity rules to curb patent abuse that can delay lower-cost drugs
Key points
- Establish patent integrity rules
- Limit patent abuse practices
Current status
Where it stands
Status
Reported
Latest action
2026-06-17 — Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
Related context
Topics and policy areas
undefinedCommerceDrug safety, medical device, and laboratory regulationInflation and pricesIntellectual propertyManufacturingPrescription drugs